Machine Learning at GSK with Kim Branson - #536

This article from Practical AI provides a concise overview of how GSK is integrating machine learning and artificial intelligence into its pharmaceutical business. It highlights key areas such as drug discovery using genetics data, the development of a massive knowledge graph for scientific literature analysis, and the creation of an AI Hub to manage infrastructure. The article also mentions a cancer research collaboration with King's College, showcasing the application of ML/AI in understanding individualized patient needs. The focus is on practical applications and the scale of GSK's AI initiatives.